0001683168-17-002861.txt : 20171108 0001683168-17-002861.hdr.sgml : 20171108 20171107185321 ACCESSION NUMBER: 0001683168-17-002861 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171108 DATE AS OF CHANGE: 20171107 EFFECTIVENESS DATE: 20171108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Primmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001721931 IRS NUMBER: 823006157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-298274 FILM NUMBER: 171184725 BUSINESS ADDRESS: STREET 1: 1929 EAST POINTE AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 858-205-2281 MAIL ADDRESS: STREET 1: 1929 EAST POINTE AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 D 1 primary_doc.xml X0708 D LIVE 0001721931 Primmune Therapeutics, Inc. 1929 EAST POINTE AVENUE CARLSBAD CA CALIFORNIA 92008 858-205-2281 DELAWARE None None Corporation true 2017 Paulo S Rangel 1929 East Pointe Avenue Carlsbad CA CALIFORNIA 92008 Executive Officer Director James R Appleman 1929 East Pointe Avenue Carlsbad CA CALIFORNIA 92008 Executive Officer Director Todd J Harris 1929 East Pointe Avenue Carlsbad CA CALIFORNIA 92008 Director Other Technology Decline to Disclose 06b false 2017-10-18 true true false 0 1500000 670000 830000 false 17 0 0 360000 A portion of the proceeds will be used to pay salaries of executive officers. false Primmune Therapeutics, Inc. /s/ Paulo S. Rangel Paulo S. Rangel President 2017-11-07